PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

About 9 in 10 haven’t heard of condition that affects nearly 90% of U.S. adults

American Heart Association survey finds most U.S. adults haven’t heard of cardiovascular-kidney-metabolic syndrome but want to learn more

2025-10-20
(Press-News.org) Embargoed until 4 a.m. CT / 5 a.m. ET Monday, Oct. 20, 2025

DALLAS, Oct. 20, 2025 — About 9 in 10 U.S. adults have not heard of cardiovascular-kidney-metabolic (CKM) syndrome, a newly defined health condition affecting nearly 90% of adults that includes heart disease, kidney disease, diabetes and obesity, according to a new survey from the American Heart Association, a relentless force changing the future of health for everyone everywhere. However, many are interested in learning more about it.

Nearly 90% of U.S. adults have at least one risk factor for CKM syndrome[1], including high blood pressure, abnormal cholesterol, high blood glucose (sugar), excess weight and reduced kidney function. The interplay of these risk factors increases the risk for heart attack, stroke and heart failure more than any one of them alone. For most of them, CKM syndrome is reversible with changes to their eating pattern, physical activity and appropriate treatment.[2],[3]

“We want people to know that it’s really common to have heart, kidney and metabolic risk factors at the same time. It is reassuring that once the CKM connection was defined nearly three-quarters of those responding understood that it was important and wanted to learn more,” said Eduardo Sanchez, M.D., FAHA, the American Heart Association’s chief medical officer for prevention.

CKM health includes the heart, kidneys and metabolic system (responsible for creating, using and storing energy, which affects weight and blood glucose level). These systems are connected and function together. When one system is functioning poorly, it can make the others worse. This creates a cycle that puts your health at serious risk for CKM syndrome. The Association will issue the first ever guidelines on CKM syndrome in early 2026.

Key findings from the new survey:

12% of U.S. adults had never heard of CKM health or CKM syndrome 79% agreed that it is important that they understand more about CKM health and 72% said they are interested in learning more about it People are most interested in learning about how CKM syndrome is treated (72%) and diagnosed (71%) 68% of U.S. adults incorrectly believe it’s best to manage individual conditions one at a time or weren’t sure of the best way to manage them 42% believed that a healthy heart would not likely be damaged by other organ systems or weren’t sure “The heart, kidney and metabolic systems are connected and, as such, should be treated in a coordinated way,” Sanchez said. "These results reveal the need to emphasize those connections and help patients understand the importance of collaborative care.”

The American Heart Association’s CKM Health Initiative™ is providing a website and educational resources to help people understand how heart, kidney and metabolic health are connected and take action early to prevent a heart attack, heart failure or stroke. The Association is also working with healthcare teams across the country to improve collaboration among health care professionals who care for patients living with multiple health conditions.

A new video helps by clarifying “2 truths” about heart health with a simplified visual and explanation (watch the video here):

The heart pumps blood to the body The metabolic system turns glucose (sugar) from the blood into energy The process of metabolism dumps waste back into the blood The kidneys filter waste from the blood and balance fluids, which helps with blood pressure Blood pressure affects how the heart pumps blood into the body “CKM health is about your overall health,” said Sanchez. “It’s a full circle. You can take care of your overall health with regular checks of your blood pressure, cholesterol, weight, blood sugar and kidney function.”

The Harris Poll conducted a survey in August 2025 on behalf of the Heart Association to gauge public awareness of CKM syndrome and CKM health. About 4,000 U.S. adults were surveyed. Health care professionals can access resources on interdisciplinary care and information about joining the CKM Health Initiative at heart.org/CKMtools. The American Heart Association’s Cardiovascular-Kidney-Metabolic Health Initiative is made possible by Founding Sponsors Novo Nordisk® and Boehringer Ingelheim,Supporting Sponsors Novartis Pharmaceuticals Corporation and Bayer, and Champion Sponsor DaVita®.

Additional Resources:

Multimedia is available on the right column of release link. House Calls, featuring Dr. Sanchez (video) What is CKM Syndrome? Think you have CKM syndrome? Here’s what to do next. Your Health is Connected (PDF) Myth vs Fact: Understanding CKM syndrome (PDF) Follow AHA/ASA news on X @HeartNews The American Heart Association/American Stroke Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association’s overall financial information are available here.

###

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.

Research Methodology

The research was conducted online in the United States by The Harris Poll on behalf of  the American Heart Association among 4,007 US adults aged 18+. The survey was conducted 8/6 - 8/22/2025.

Data are weighted where necessary by education, age by gender, race/ethnicity, region, household income, size of household, marital status, employment, and smoking status to bring them in line with their actual proportions in the population.Respondents for this survey were selected from among those who have agreed to participate in our surveys.

The sampling precision of Harris online polls is measured by using a Bayesian credible interval. For this study, the sample data is accurate to within ± 2.0 percentage points using a 95% confidence level. This credible interval will be wider among subsets of the surveyed population of interest. All sample surveys and polls, whether or not they use probability sampling, are subject to other multiple sources of error which are most often not possible to quantify or estimate, including, but not limited to coverage error, error associated with nonresponse, error associated with question wording and response options, and post-survey weighting and adjustments.

[1] https://jamanetwork.com/journals/jama/fullarticle/2818457

[2] Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association

[3] Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011-2020 | JAMA

END


ELSE PRESS RELEASES FROM THIS DATE:

Personalized brain stimulation offers new hope for people with hard-to-treat epilepsy

2025-10-20
PITTSBURGH, October 20, 2025 — Doctors and researchers at the University of Pittsburgh and UPMC have developed a new treatment for epilepsy patients who don’t respond to medication and aren’t candidates for surgery. Their approach, published today in Nature Communications, uses deep brain stimulation (DBS) that is tailored to each patient’s unique brain wiring. Epilepsy affects more than 50 million people worldwide, and about a third of those do not respond to medication. For some, seizures are generated in parts of the brain that control essential functions – speech, movement or vision – that can’t be safely removed. Brain ...

The tiny droplets that bounce without bursting

2025-10-20
If you’ve ever added liquid to a hot frying pan, maybe you noticed how the droplets bubbled up and skittered across the sizzling surface, rather than immediately flattening and wetting. This happens because the pan’s heat starts boiling the undersides of the droplets, producing vapor that acts as an insulating cushion on which they can – momentarily – dance. Previously, scientists have produced a room-temperature version of this phenomenon – known as the Leidenfrost effect – ...

Immunotherapy after surgery shows promise in treating rare, aggressive skin cancer

2025-10-20
Note: Abstract #6267, titled ECOG-ACRIN EA6174: Surgically Treated Adjuvant Merkel Cell Carcinoma with Pembrolizumab, is scheduled to be presented during the European Society for Medical Oncology meeting on Monday, Oct. 20, at 2:30 a.m. ET in the Cologne Auditorium, Messe Berlin, Berlin. A drug that harnesses the immune system to attack cancer cells has proved successful in preventing a rare and aggressive form of skin cancer from spreading to other organs when given immediately after surgery, a new study shows. Led by researchers at NYU ...

Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer

2025-10-20
A new cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) shows that a drug that utilizes the body’s immune system to target and eliminate cancer cells appeared to reduce the risk of distant metastases for an aggressive form of skin cancer when given immediately after surgery, but did not significantly reduce the overall risk of recurrence, which was a co-primary endpoint of the trial. The randomized phase 3 STAMP trial (EA6174) is the largest clinical study to date evaluating pembrolizumab, ...

What is the extent of disparities in cancer clinical trials among low- and middle-income countries?

2025-10-20
New research reveals that the number and complexity of cancer clinical trials since 2001 have varied across low- and middle-income countries (LMICs), with economic growth contributing to disparities, but only to a certain extent. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society. Although LMICs are expected to experience the greatest global burden of cancer in the coming years, cancer clinical trials are disproportionally concentrated in high-income countries. Because evidence suggests that LMICs have increased the number of cancer clinical trials over the last few decades, researchers investigated disparities ...

Invisible poison: Airborne mercury from gold mining is contaminating African food crops, new study warns

2025-10-20
In a recent study published today in the European Geosciences Union (EGU) journal Biogeosciences, scientists have confirmed that mercury pollution from artisanal and small-scale gold mining (ASGM) is contaminating food crops not through the soil, as previously believed, but directly from the air. Driven by the surging price of gold, which has increased by more than tenfold since 2000, the rapid expansion of unregulated mining in these regions raises urgent questions about food security, human health, and environmental justice The study, conducted by an international team of scientists led by Excellent ...

Nearly half of Finns with chronic conditions find medication therapy a burden

2025-10-20
According to a recent study, 44% of people with chronic conditions who responded to a population-based survey experienced medication-related burden (MRB). The burden was most common among people with diabetes, heart disease, rheumatic disease or some other musculoskeletal disorder. The greatest burden was caused by factors associated with health care, such as fragmented care and the cost of medicines, as well as adverse drug reactions or concerns about them.  “Other factors linked with MRB were poor health status, limits on functional capacity and low income,” says Pharmacist and Doctoral Researcher Heidi Mikkola from the School of Pharmacy at the University of ...

Do animals fall for optical illusions? What fish and birds can teach us about perception

2025-10-20
Have you ever looked at two circles of exactly the same size and sworn one was larger? If so, your eyes have been tricked by the Ebbinghaus illusion, a classic example of how context can shape what we see. Place a circle among other smaller circles, and it seems bigger; place it among larger ones, and it shrinks before our eyes. This illusion fascinates psychologists because it reveals that perception is not a mirror of the outside world but a clever construction of the brain. But here is the question that inspired our study: do other animals fall for the same tricks? If a tiny fish or a bird perceives ...

New guideline emphasizes conversations about mood, mental health between patients and clinicians

2025-10-20
Depression is a mental illness, and support for depression can improve emotions, thoughts, and well-being. A new guideline from the Canadian Task Force on Preventive Health Care recommends that patients aged 18 and older talk to their health care providers about depression rather than undergo routine screening with standard tools, like questionnaires. The guideline is published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.250237. In Canada, depression is common, with about 1 in 10 people (without bipolar disorder) experiencing depression in their lifetimes. It negatively affects how a person ...

Children’s Hospital of Philadelphia researchers observe significant reduction in diagnosis of food allergies following expert guidelines encouraging early peanut exposure

2025-10-20
Philadelphia, October 20, 2025 – Peanuts represent one of the most common causes of immunoglobulin E (IgE)-mediated, or anaphylactic, food allergies in children, yet a landmark study found that early introduction of peanut to infants may lower their risk of developing this allergy. Now, a new study from researchers from Children’s Hospital of Philadelphia (CHOP) has shown that the rates of diagnosis of peanut and other IgE-mediated food allergies have declined since the adoption of guidelines encouraging early introduction practices. The findings, published today ...

LAST 30 PRESS RELEASES:

Retinal implant restores central vision in patients with advanced AMD, study co-led by Pitt investigator shows

Eye prosthesis is the first to restore sight lost to macular degeneration

Pioneering eye device restores reading vision to blind eyes

Subretinal implant partially restores vision in AMD patients

3D printed antenna arrays developed for flexible wireless systems

When is the brain like a subway station? When it’s processing many words at once

Important phenomenon discovered in the Arctic – could boost marine life

New white paper urges policymakers to modernize practice laws to unlock AI’s full potential in healthcare

Unmasking the culprits of battery failure with a graphene mesosponge

AASM announces finalists for first Sleep Medicine Disruptors Innovation Award

Combination therapy could expand treatment options for AML patients, extend survival

Microscopic DNA ‘flowers’ could deliver medicine exactly where it’s needed

Hormone therapy alters body proteins to match gender identity

Eat, explore, rest: a leptin-sensing brain circuit helps overcome anxiety to meet vital needs

2D devices have hidden cavities that can modify electronic behavior

Experts urge risk-based monitoring as Barrett’s esophagus care moves beyond one-size-fits-all

How multiple sclerosis harms a brain long before symptoms appear

Did marine life in the palaeocene use a compass?

About 9 in 10 haven’t heard of condition that affects nearly 90% of U.S. adults

Personalized brain stimulation offers new hope for people with hard-to-treat epilepsy

The tiny droplets that bounce without bursting

Immunotherapy after surgery shows promise in treating rare, aggressive skin cancer

Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer

What is the extent of disparities in cancer clinical trials among low- and middle-income countries?

Invisible poison: Airborne mercury from gold mining is contaminating African food crops, new study warns

Nearly half of Finns with chronic conditions find medication therapy a burden

Do animals fall for optical illusions? What fish and birds can teach us about perception

New guideline emphasizes conversations about mood, mental health between patients and clinicians

Children’s Hospital of Philadelphia researchers observe significant reduction in diagnosis of food allergies following expert guidelines encouraging early peanut exposure

ESMO 2025: VT3989 continues to show promising early results in patients with advanced mesothelioma

[Press-News.org] About 9 in 10 haven’t heard of condition that affects nearly 90% of U.S. adults
American Heart Association survey finds most U.S. adults haven’t heard of cardiovascular-kidney-metabolic syndrome but want to learn more